Skip to content

AIDX

20/20 Biolabs, Inc. Common Stock

NASDAQ · Healthcare · Medical - Devices · US

$0.59
−3.27%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-27.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Apr 6, 2026Bergman Alan B. · officer: Chief Financial OfficerA-Award100,000$1.88
Apr 6, 2026Zhou Jiming · officer: Chief Operating OfficerA-Award150,000$1.88
Mar 4, 2026Cohen Jonathan M · director, 10 percent owner, officer: Chief Executive OfficerA-Award352,936$3.39
Institutional positioning

13F filings over the trailing two quarters

New 7Increased 1Reduced 0Sold out 6
FilerActionSharesFiled
CRESSET ASSET MANAGEMENT, LLCNew Position264,368May 15, 2026
CITADEL ADVISORS LLCIncreased23,205Sep 2, 2026
CITADEL ADVISORS LLCNew Position16,227May 15, 2026
XTX TOPCO LTDNew Position10,329May 15, 2026
UBS GROUP AGNew Position8,314May 5, 2026
MAI CAPITAL MANAGEMENTNew Position1,000May 15, 2026
TOTH FINANCIAL ADVISORY CORPNew Position157Apr 16, 2026
ALLWORTH FINANCIAL LPNew Position30May 15, 2026
Cresset Asset Management, LLCSold Out0May 15, 2026
UBS Group AGSold Out0May 5, 2026
TOTH FINANCIAL ADVISORY CORPSold Out0Apr 16, 2026
MAI Capital ManagementSold Out0May 15, 2026
Allworth Financial LPSold Out0May 15, 2026
XTX Topco LtdSold Out0May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 6, 2026